Healthcare Marketing Blogs
08|06|26
What ChatGPT Ads Mean for Pharma Search
Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.
07|29|26
Omnideployment: The Future of Pharmaceutical Commercialization
Discover how omnideployment is helping pharmaceutical organizations connect digital engagement, AI-powered content and field execution to drive smarter HCP interactions, stronger engagement and better outcomes.
07|09|26
Human Scarcity in an AI-First World: Cannes Lions 2026
In a world flooded with AI-generated content, the brands that stand out are proving their humanity. Discover five insights from Cannes Lions 2026 that every pharma marketer should know.
06|23|26
Navigating the New Era of Pharma Search with Google AI Overviews
As Google AI Overviews increasingly become the front door for pharmaceutical discovery, life science brands must adapt their strategies to maintain visibility in a changing search landscape. Josie Black, Head of SEO and GEO, explored this rapid shift to AI-powered, synthesized answers in discussion with pharmaphorum.
05|21|26
Pharma’s AI Influencer Future Depends on One Question: Why Would Anyone Care?
In a new article published on Med Ad News (Pharma Live), Chief Creative Officer Susan Perlbachs explores what recent consumer backlash to AI influencers reveals about the future of influence in healthcare. The takeaway isn’t that audiences reject AI, but that they reject anything that lacks perspective, purpose, or genuine human value.
05|11|26
What Adobe Summit 2026 Signals for Pharma Marketing
Adobe Summit 2026 highlighted a major shift in AI, uncovering new implications for how marketing gets done in pharma. Our latest POV from our team that attended this year’s summit explores what this shift means and how pharma marketers can start preparing for what’s next. Readers will gain insight into: Download the POV to learn more.
03|17|26
4th Annual Brand Planning Report: Fueling Brand Plan Success Through AI‑Powered Integration
In our fourth annual report, Chief Strategy Officer at EVERSANA INTOUCH, John Kenny, and Senior Partner of EVERSANA MANAGEMENT CONSULTING, Sean Rapson, explore the state of brand planning with input from pharma marketing executives, uncovering persistent gaps in efficiency, consistency, and the ability to harness data effectively.
03|04|26
Rare Disease in Focus: How Innovation Is Accelerating Access for Patients
The rare disease landscape has long been defined by delay, with families frequently facing 7–10 years before receiving a diagnosis. In recognition of Rare Disease Day, Ann Cave, President, Full-Service Agency, wrote an article for PM360 spotlighting how innovation and human insight are reshaping the rare disease landscape.
03|02|26
Creative That Connects: Earning Trust in Rare Disease Communities
In honor of Rare Disease Day, Patrick Brodfuehrer penned an article in Med Ad News that explores what authentic connection really means for the 300 million people worldwide living with a rare disease.
02|13|26
The “Pharma Bowl”: How Super Bowl 60 Became Pharma’s Biggest Stage
From GLP‑1 dominance to celebrity‑driven disease awareness, Super Bowl 60 marked a tipping point in how healthcare brands show up on the world’s biggest advertising stage. What was once considered a high‑risk investment is now a calculated brand‑building move, signaling a shift in how pharma thinks about cultural relevance, storytelling, and long‑term equity.